267 filings
Page 11 of 14
8-K
w3bxkug40sw 962b
8 Mar 17
Heat Biologics Announces Agreement to Acquire Pelican Therapeutics
12:00am
8-K
xv7s5cje23g e9
3 Feb 17
Other Events
12:00am
8-K
yxvfw33kydtcdlug i6u
6 Jan 17
Regulation FD Disclosure
12:00am
8-K
7vtap9o81ib
4 Jan 17
Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer
12:00am
8-K
m8qxaaxq38i3s9mg
9 Dec 16
Termination of a Material Definitive Agreement
12:00am
8-K
ygioa cq3ptq
6 Dec 16
Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results
12:00am
8-K
wsvpvc
1 Dec 16
Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting
12:00am
8-K
58d levay8h
10 Nov 16
Heat Biologics Provides Corporate Update and Reports Third Quarter 2016 Financial Results
12:00am
8-K
2w2204a2 b7
6 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
xiv3np
18 Aug 16
Other Events
12:00am
8-K
ssvtuvb7bsc5u h3oken
15 Aug 16
Heat Biologics Provides Corporate Update and Reports Second Quarter 2016 Financial Results
12:00am
8-K
vfpp 27v4hrm
15 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
i5to r7jvrq
21 Jul 16
Material Modifications to Rights of Security Holders
12:00am
8-K
ledgniu43687 6sc6p3q
1 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
v74 52i1s2mhx9qc
6 Jun 16
Regulation FD Disclosure
12:00am
8-K
jk1mvq 1u
11 May 16
Heat Biologics Reports First Quarter 2016 Financial Results
12:00am
8-K
q39mg9dd
3 May 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
sn0k03ftxtfcy5n80
25 Apr 16
Heat Biologics Appoints Dr. John Prendergast to Board of Directors
12:00am
8-K
odvwsq88
7 Apr 16
Heat Biologics Announces Cost-Saving Measures and Focused Corporate Strategy to Achieve Important Clinical Milestones
12:00am
8-K
ofbwcex mt3lis4gelfa
24 Mar 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am